Publishing a failed test is the most consequential thing The Peptide Institute does, and it follows a fixed protocol: confirmation from a second lot at a second laboratory, advance notice to the company, a published dispute window, and full laboratory documentation released with the report.
Companies respond in patterns — some remediate and retest publicly, some dispute, some go silent. Each path has defined score consequences, documented in our methodology. The June Cascade Research Group case is this protocol’s most recent full execution, and every step is public.
